DICE — Dice Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $2.27bn
- $1.72bn
Annual cashflow statement for Dice Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -12.9 | -23.7 | -49 | -83.9 |
| Depreciation | ||||
| Non-Cash Items | 0.583 | 0.7 | 7.36 | 16.1 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -4.65 | 1.66 | 1.65 | 2.64 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -16.3 | -20.7 | -39.3 | -64.3 |
| Capital Expenditures | -0.981 | -0.148 | -0.718 | -2.24 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -18.2 | 18.2 | -204 | 89.7 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -19.1 | 18 | -205 | 87.5 |
| Financing Cash Flow Items | 0 | -0.331 | -0.045 | -0.226 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -0.278 | 53.9 | 300 | 322 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -35.7 | 51.2 | 56.3 | 345 |